PI3K/Akt signaling pathway involved in regulation of T lymphocyte activation and apoptosis mediated by CD3ε

被引:2
|
作者
Zhang, J [1 ]
Liu, YX [1 ]
Liu, SL [1 ]
Zheng, DX [1 ]
机构
[1] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China
来源
CHINESE SCIENCE BULLETIN | 2001年 / 46卷 / 07期
基金
中国国家自然科学基金;
关键词
apoptosis; CD8 epsilon chimera; T lymphocyte; PI3K; Akt;
D O I
10.1007/BF02900411
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To study the expression and kinase activity of phosphatidylinositol 3 ' -kinase (PI3K) and protein kinase B (PKB or Akt) during activation and apoptosis of human Jurkat T lymphocytes (TJK) with stable expression of CD8 epsilon chimera fused human CD8 alpha extracellular and transmembrane domains to intracellular domain of mouse CD3 epsilon, Western blot, kinase activities detection and immunoprecipitation were carried out. It was shown that Jurkat cells with expression of wild type chimera CD8 epsilon died by apoptosis after continuous stimulation of anti-CD8 monoclonal antibody. The expressions of PI3K and Akt, and the kinase activity of Akt remarkably increased during the process, However, this phenomenon did not occur in the Jurkat cells (T1JK) with expression of the mutant of CD8 epsilon chimera (Y170F), suggesting that PI3K/Akt signaling pathway is involved in activation and apoptosis of T lymphocyte mediated by CD3 epsilon.
引用
收藏
页码:568 / 570
页数:3
相关论文
共 50 条
  • [21] The effects of Ginsenosides on PI3K/AKT signaling pathway
    Ghafouri-Fard, Soudeh
    Balaei, Neda
    Shoorei, Hamed
    Hasan, Syed Muhammad Farid
    Hussen, Bashdar Mahmud
    Talebi, Seyedeh Fahimeh
    Taheri, Mohammad
    Ayatollahi, Seyed Abdulmajid
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (07) : 6701 - 6716
  • [22] PI3K–Akt signaling controls PFKFB3 expression during human T-lymphocyte activation
    Helga Simon-Molas
    Claudia Arnedo-Pac
    Pere Fontova
    Anna Vidal-Alabró
    Esther Castaño
    Ana Rodríguez-García
    Àurea Navarro-Sabaté
    Núria Lloberas
    Anna Manzano
    Ramon Bartrons
    Molecular and Cellular Biochemistry, 2018, 448 : 187 - 197
  • [23] Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
    Kawauchi, Kiyotaka
    Ogasawara, Toshie
    Yasuyama, Masako
    Otsuka, Kuniaki
    Yamada, Osamu
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (09) : 1024 - 1038
  • [24] The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway
    Yao, Hong
    Han, Xiangyang
    Han, Xiuzhen
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (06) : 433 - 442
  • [25] The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway
    Hong Yao
    Xiangyang Han
    Xiuzhen Han
    American Journal of Cardiovascular Drugs, 2014, 14 : 433 - 442
  • [26] Activation of the PI3K/Akt pathway and chemotherapeutic resistance
    West, KA
    Castillo, SS
    Dennis, PA
    DRUG RESISTANCE UPDATES, 2002, 5 (06) : 234 - 248
  • [27] Aberrant expression of PI3K/AKT signaling is involved in apoptosis resistance of hepatocellular carcinoma
    Wang, Zhuangqiang
    Cui, Xiaopeng
    Hao, Gaopeng
    He, Jiefeng
    OPEN LIFE SCIENCES, 2021, 16 (01): : 1037 - 1044
  • [28] PI3K/AKT pathway activation in bladder carcinogenesis
    Calderaro, Julien
    Rebouissou, Sandra
    de Koning, Leanne
    Masmoudi, Asma
    Herault, Aurelie
    Dubois, Thierry
    Maille, Pascale
    Soyeux, Pascale
    Sibony, Mathilde
    de la Taille, Alexandre
    Vordos, Dimitri
    Lebret, Thierry
    Radvanyi, Francois
    Allory, Yves
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (08) : 1776 - 1784
  • [29] Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway
    Naughton, R.
    Quiney, C.
    Turner, S. D.
    Cotter, T. G.
    LEUKEMIA, 2009, 23 (08) : 1432 - 1440
  • [30] Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway
    R Naughton
    C Quiney
    S D Turner
    T G Cotter
    Leukemia, 2009, 23 : 1432 - 1440